Pure Global
NCT06019416

Culturally Tailored Mindfulness-Positive Psychological Intervention Using Virtual Reality

Discrimination and Mental Health of Older Korean Adults in the U.S.: Feasibility and Pilot Trial of a Culturally Tailored Mindfulness-Positive Psychological Intervention Using Virtual Reality
University of Illinois at Urbana-Champaign·ClinicalTrials.gov·behavioralCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mental Health Issue
Drug/Device/Intervention
culturally tailored mindfulness-positive psychological intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Illinois at Urbana-Champaign
Location
Chicago,Chicago,Urbana, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 31, 2023
End date
May 19, 2023
Enrollment
31 participants
Primary outcome

Racism-related stress

Summary

This study is to explore the experience of older Korean adults with anti-Asian racism in the
 U.S. and investigate the feasibility, acceptability, and preliminary efficacy of a virtual
 reality-based culturally tailored mindfulness-positive psychological intervention. Primary
 outcome is racism-related stress and secondary outcomes are negative mental health (e.g.,
 anxiety, depressive symptoms, and anxiety) and positive psychological well-being (e.g.,
 positive affect, optimism, life engagement, mindful attention awareness).

ICD-10 classifications
Mental disorder, not otherwise specifiedMental and behavioural disordersUnspecified mental disorderProblems related to certain psychosocial circumstancesProblems related to other psychosocial circumstances
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06019416
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06019416 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Illinois at Urbana-Champaign and is currently Completed. The study focuses on Mental Health Issue. Target enrollment is 31 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.